Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-27

Clinical Trial Update: Esmolol Versus Dexmedetomidine During Intracranial Procedures [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing esmolol to dexmedetomidine during intracranial procedures, sponsored by George Papanicolaou Hospital, involving intracranial an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Esmolol (esmolol)

Snippet

Sponsor: George Papanicolaou Hospital | Conditions: Intracranial Aneurysm, Intracranial Neoplasms | Phase 3 | Status: UNKNOWN